Guangzhou Baiyunshan Pharmaceutical Holdings (00874): Tianxin Pharmaceutical has received the "Approval Notification for Supplementary Application of Sodium Cytidine Injection (2ml: 0.25g, 4ml: 0.5g)."
Baiyun Mountain (00874) announced that recently, the companys holding subsidiary Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. (hereinafter referred to as Tianxin Pharmaceutical) received the "Approval Notice for Supplementary Application for Drugs" issued by the National Medical Products Administration for Sodium Cyclic Phosphatidic Acid Injection (2ml: 0.25g, 4ml: 0.5g).
Guangzhou Baiyunshan Pharmaceutical Holdings (00874) announced that its holding subsidiary, Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. (hereinafter referred to as "Tianxin Pharmaceutical"), has recently received the Approval Notice for Drug Supplement Application issued by the National Medical Products Administration for Sodium Citicoline Injection (2ml: 0.25g, 4ml: 0.5g).
The approval of the Supplement Application for Sodium Citicoline Injection (2ml: 0.25g, 4ml: 0.5g) allows Tianxin Pharmaceutical to expand the specifications of this product and pass the consistency evaluation of quality and efficacy for generic drugs, which is beneficial for enhancing the market competitiveness of this product.
Related Articles
YTO INTL EXP (06123): Wang Lixiu resigned as a non-executive director.
NANSHAN AL INTL (02610) announced its interim results, with shareholders' profit attributable to them at $62.7 million, a decrease of 74.8% compared to the previous year.
TYSAN HOLDINGS (00687) will distribute an interim dividend of HKD 0.03 per share on September 25th.
YTO INTL EXP (06123): Wang Lixiu resigned as a non-executive director.
NANSHAN AL INTL (02610) announced its interim results, with shareholders' profit attributable to them at $62.7 million, a decrease of 74.8% compared to the previous year.
TYSAN HOLDINGS (00687) will distribute an interim dividend of HKD 0.03 per share on September 25th.
RECOMMEND
